TAP Block With Two Different Doses of Levobupivacaine

• Status: Unknown status
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the current study is to investigate the effects of two different doses of levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For this purpose we planned to include 50 children aged between 2 and 12 that will undergo unilateral inguinal surgery.

The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ankara University
• Treatments: Bupivacaine; Levobupivacaine

Criteria

Inclusion Criteria:

• Volunteers planned to undergo unilateral inguinal surgery under TAP (ilioinguinal and iliohypogastric block) and general anesthesia

• Aged between 2 and 12

Exclusion Criteria:

• Patients with coagulation dysfunction

• Patients with chronic pain

• Patients having infection at the site of intervention

• Patients with a history of allergy

• Patients having chronic diseases (hepatic dysfunction, renal failure)